2011 American Society of Breast Surgeons Annual Meeting

Breast Cancer

Caroline Helwick  / June 15 2011  / 2011 American Society of Breast Surgeons Annual Meeting

More Evidence Links Vitamin D Deficiency to Breast Cancer

Patients with breast cancer and deficient levels of 25-hydroxy-vitamin D are more likely to have aggressive tumor profiles and unfavorable prognostic markers than women with optimal levels of vitamin ...

Breast Cancer

Caroline Helwick  / June 15 2011  / 2011 American Society of Breast Surgeons Annual Meeting

Radiotherapy in DCIS: Recurrence Patterns Are Different

For women with ductal carcinoma in situ (DCIS), radiation therapy after excision is not a slam-dunk in terms of benefits, according to a study presented at the American Society of Breast Surgeons 12th...

Advertisement

Advertisement



Aug
22
Today In Oncology
Early-Phase Study Finds Vitamin C May Activate TET2 Function
Comparison of Screening Recommendations for Mammography
Screening for Occult Cancer in Patients With Unprovoked Venous Thromboembolism
Adjuvant Temozolomide in 1p/19q Non–Co-deleted Anaplastic Glioma
AKT Inhibitor Ipatasertib in Metastatic Triple-Negative Breast Cancer
Liquid Biopsies Identify Distinct Genomic Profiles With Potentially Targetable Alterations in Carcinoma of Unknown Primary
Detection of Early-Stage Cancers With Circulating Tumor DNA
Arsenic Trioxide and Reduced Anthracycline Dose in Pediatric Acute Promyelocytic Leukemia
View More 
Advertisement
Most Read Stories
FDA Approves Olaparib Tablets for Maintenance Treatment in Ovarian Cancer
First-Line Cabazitaxel vs Docetaxel in Metastatic Castration-Resistant Prostate Cancer
Partial-Breast and Reduced-Dose Radiotherapy After Breast-Conserving Surgery
Searching for Happiness
ASCO Guideline on Stage IV NSCLC Therapy Updated
KEYNOTE-010 Update Shows ‘Striking’ Durability of Second-Line Pembrolizumab in NSCLC
Surveillance Mammography by Life Expectancy in Older Breast Cancer Survivors
Final Overall Survival Results of GOG 240 Trial Adding Bevacizumab to Chemotherapy in Advanced Cervical Cancer
Genomic Characteristics and Immune Infiltration in Triple-Negative Breast Cancer
CheckMate-214: Nivolumab and Ipilimumab in Intermediate- and Poor-Risk Previously Untreated Advanced or Metastatic RCC
© 2016 HSP News Service, L.L.C.